On this page
Ca-AKG and AAKG share three letters and almost nothing else. One is a longevity supplement backed by mouse lifespan data. The other is a bodybuilding supplement whose marketing has run substantially ahead of its exercise evidence. Confusing them will not hurt you — but it will mean spending money on the wrong compound for your goal.
This guide separates them properly. Every claim links back to a paper page in our Ca-AKG Data Center. For the wider evidence overview on Ca-AKG itself, see our pillar: calcium alpha-ketoglutarate — the complete evidence-based guide.
Ca-AKG and AAKG in one sentence each
Ca-AKG is a calcium salt of alpha-ketoglutarate, taken for its potential effects on healthy ageing, biological age, and cellular metabolism.
AAKG is arginine alpha-ketoglutarate, taken mostly by bodybuilders and endurance athletes for its supposed effects on nitric oxide, blood flow, and muscle pump.
Both compounds contain the same core molecule — alpha-ketoglutarate. The partner molecule is what makes them behave differently.
The name game — what do "Ca-AKG" and "AAKG" actually stand for?
The confusion starts with the naming, so it is worth being precise.
AKG is alpha-ketoglutarate — the small molecule that sits in the middle of the Krebs cycle inside every one of your cells. Your body makes it continuously. If you want the plain-English introduction to AKG, start with what is Ca-AKG.
Ca-AKG is calcium alpha-ketoglutarate. The AKG is bound to a calcium ion, forming a stable salt that can be packaged into a capsule and survive the stomach. The calcium is a delivery vehicle.
AAKG is arginine alpha-ketoglutarate. Here the AKG is bound to arginine — a specific amino acid that your body uses to make nitric oxide. The idea behind AAKG is that arginine, delivered as a paired salt, would raise nitric oxide production and improve blood flow to working muscles.
So Ca-AKG and AAKG both deliver AKG. What is different is what they deliver alongside it — and what that partner molecule does.
Side-by-side comparison
The most useful way to see the difference is in one table.
| Feature | Ca-AKG | AAKG |
|---|---|---|
| Full name | Calcium alpha-ketoglutarate | Arginine alpha-ketoglutarate |
| Partner molecule | Calcium (a mineral) | L-arginine (an amino acid) |
| Primary use case | Longevity, healthy ageing, biological age | Exercise performance, muscle pump, endurance |
| Typical dose | 1,000 mg/day | 3,000–10,000 mg/day |
| Longevity evidence | Mouse lifespan data, early human observational data | Essentially none |
| Exercise evidence | Preclinical muscle and frailty data only | Meta-analysis positive but heterogeneous, with publication bias flags |
| Clinical use history | Decades in kidney medicine and postmenopausal osteopenia | No formal clinical use |
| Main safety consideration | Calcium load (200 mg per 1 g); kidney stone history | Arginine dose (herpes reactivation, blood pressure) |
| Ongoing human trials | ABLE, NCT07114536 — reading out 2026 | None specifically for AAKG longevity |
Different molecule pair. Different dose. Different evidence base. Different use case.
What Ca-AKG is used for
Ca-AKG is a longevity supplement. That is the entire category it competes in.
The scientific rationale traces back to a 2020 mouse study at the Buck Institute for Research on Aging, which found that middle-aged mice fed Ca-AKG lived longer and — more importantly — spent a much smaller proportion of their lives being frail [1]. That paper is why every longevity supplement brand you have heard of started stocking Ca-AKG. For a full paper-by-paper walkthrough, see the Shahmirzadi 2020 deep-dive.
The mechanism story is broader than lifespan. Alpha-ketoglutarate is a required cofactor for enzymes that regulate the epigenome, and a 2014 Nature paper showed it also inhibits the TOR growth pathway — the same pathway targeted by the longevity drug rapamycin [2]. For the full mechanism walkthrough, see how Ca-AKG works.
Human evidence for Ca-AKG is still early. A 2022 review in Trends in Endocrinology and Metabolism catalogued the human AKG literature and concluded the compound was worth serious clinical study [3]. Two randomised trials are reading out in 2026.
What Ca-AKG is not used for: exercise performance. It has never been marketed as an ergogenic aid, and no serious exercise-performance research programme uses it.
What AAKG is used for — and what the exercise research actually shows
AAKG was developed for the sports supplement market. The pitch is straightforward: L-arginine is the amino acid precursor to nitric oxide, nitric oxide dilates blood vessels, dilated blood vessels deliver more oxygen and nutrients to working muscle, and therefore AAKG improves exercise performance.
The pitch is more compelling than the underlying evidence, and the honest read of the meta-analytic literature is caveated.
The most-cited pooled analysis is a 2020 systematic review and meta-analysis in Nutrients that combined 15 randomised trials using arginine in various forms, including AAKG [5]. The headline result was a large positive effect on aerobic performance (Hedges' g = 0.84) and a small positive effect on anaerobic performance (g = 0.24). Both reached statistical significance.
Those headline numbers should be read with care. Heterogeneity between studies was very high for the aerobic result (I² = 89%), meaning the pooled trials disagreed strongly with each other. The authors' own funnel plot showed statistically significant publication bias in the aerobic data. A 2025 formal comment in the same journal documented methodological errors in the meta-analysis — outlier handling and standard-error/standard-deviation confusion — which the original authors partially acknowledged in a formal reply. The pooled effect also mixes L-arginine, arginine aspartate, and AAKG without distinguishing between them, so the specific AAKG effect cannot be extracted from the aggregate.
The wider picture is consistent with this. Orally administered L-arginine has poor bioavailability because of first-pass metabolism by the enzyme arginase — the amount reaching systemic circulation is a small fraction of the dose swallowed. For meaningful acute increases in circulating arginine, L-citrulline (arginine's precursor) has generally outperformed L-arginine head-to-head. This is why sports supplements have been shifting from arginine-based to citrulline-based formulations for over a decade.
None of this means AAKG is useless. Some people report subjective benefit, the safety profile at typical doses is acceptable, and the meta-analytic signal is directionally positive. But the effect is not the "settled ergogenic aid" the marketing implies, and much of the retailer positioning ignores both the methodological caveats and the market's own shift toward citrulline.
For the fuller Ca-AKG picture on muscle and frailty — which is separate and preclinical — see Ca-AKG for muscle, frailty and sarcopenia.
Are they interchangeable?
No. Not for either goal.
For longevity: use Ca-AKG. Every study underpinning the longevity story — the Shahmirzadi mouse work, the Rejuvant human retrospective, the 2026 Pabis cohort, the ABLE trial, the Chinese trial — uses Ca-AKG specifically. Substituting AAKG would mean acting on the general biology of alpha-ketoglutarate while ignoring that the longevity evidence base was built on a different formulation.
For exercise performance: even AAKG is a weak choice. If you want to raise nitric oxide and support blood flow to working muscle, citrulline malate at 6–8 grams has stronger evidence than arginine-based products. AAKG is not the best-evidenced ergogenic supplement — it is simply the AKG-containing one.
Some people take both. If you are one of them, know that you are taking two supplements for two different goals — not one supplement covering both.
Is one safer than the other?
Both are broadly well tolerated at typical doses. The specific safety considerations are different.
Ca-AKG. The main practical concern is the elemental calcium load — about 200 mg per 1 g dose. Someone already taking a calcium supplement plus a fortified diet plus 2 g of Ca-AKG can readily exceed the tolerable upper intake for calcium. Anyone with a personal or family history of kidney stones should discuss added calcium with their doctor. Historical clinical use of Ca-AKG in kidney medicine — including in patients on haemodialysis — is catalogued in a 2017 review in Archivum Immunologiae et Therapiae Experimentalis and provides substantial reassurance about the compound's safety profile at supplement doses [4].
AAKG. Two considerations warrant flagging. First, oral arginine at gram-level doses can lower blood pressure — usually a modest and clinically unimportant effect, but relevant for anyone on antihypertensive medication. Second, arginine can reactivate latent herpes simplex virus infections in susceptible people; the amino acid lysine is arginine's biochemical counterpart, and the arginine-to-lysine ratio matters for HSV control. Multi-gram AAKG doses are relevant here.
Neither profile makes one supplement dangerous — but the risk calculus is genuinely different between them. The full Ca-AKG safety walkthrough lives in Ca-AKG side effects and safety profile.
Can you take both?
Yes, in principle. They act on largely different pathways and their interactions are minimal. Practically, the question is whether you actually need both — which comes down to whether you are chasing both a longevity outcome and a nitric oxide outcome.
Two practical notes. Combining them means double-dosing on alpha-ketoglutarate, which pushes your daily AKG intake beyond what any of the longevity trials have studied. And the total calcium load can climb quickly if you take Ca-AKG alongside a separate calcium supplement.
For most people, choosing one supplement matched to the actual goal is simpler and cheaper than stacking both.
Which one is right for you?
The choice is straightforward when the goal is clear.
You are interested in healthy ageing, biological age, or the broader longevity supplement conversation. Ca-AKG. It is the compound the entire longevity evidence base is built on. AAKG has essentially no longevity data.
You want to improve exercise performance and muscle pump. AAKG is one option but the peer-reviewed exercise evidence is heterogeneous and biased-flagged. Citrulline malate at 6–8 grams pre-workout has stronger evidence for the nitric oxide effect you are chasing.
You are shopping for a calcium supplement. Neither. Calcium carbonate or calcium citrate deliver more elemental calcium per capsule at a fraction of the cost.
You are unsure what you are trying to achieve. Ca-AKG has the broader biology, the deeper evidence base, and the ongoing human trials that will actually tell you whether it works in humans. That makes it the more defensible starting choice.
For a proper walkthrough of the different Ca-AKG-adjacent forms on the market — Ca-AKG, plain AKG, AAKG, ornithine AKG, sodium AKG, creatine AKG — see AKG forms explained. And for the specific Ca-AKG vs unbound AKG question, see Ca-AKG vs free AKG. If you want to skip to dose-picking, Ca-AKG dosage covers what the trial data supports.
Bottom line
Ca-AKG and AAKG share three letters and diverge on almost everything else. Ca-AKG is a longevity supplement with real preclinical data and emerging human evidence. AAKG is a sports supplement with a positive but heterogeneous meta-analytic signal that carries publication bias flags and does not distinguish AAKG from other arginine forms.
For longevity: Ca-AKG. For exercise: probably not AAKG. For confusion: this article. The rest of the picture — trial evidence, dose, safety, forms — is in the Ca-AKG pillar.